These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1348 related articles for article (PubMed ID: 30841935)

  • 1. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance for reporting outcomes in clinical trials: scoping review protocol.
    Butcher NJ; Mew EJ; Saeed L; Monsour A; Chee-A-Tow A; Chan AW; Moher D; Offringa M
    BMJ Open; 2019 Feb; 9(2):e023001. PubMed ID: 30782872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.
    Butcher NJ; Mew EJ; Monsour A; Chan AW; Moher D; Offringa M
    Trials; 2020 Jul; 21(1):620. PubMed ID: 32641085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
    Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
    Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
    Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
    Trials; 2015 Sep; 16():417. PubMed ID: 26385379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
    Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
    JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
    Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
    BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).
    Kirkham JJ; Gorst S; Altman DG; Blazeby J; Clarke M; Devane D; Gargon E; Williamson PR;
    Trials; 2015 Aug; 16():373. PubMed ID: 26297658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.
    Tunn R; Boutron I; Chan AW; Collins GS; Hróbjartsson A; Moher D; Schulz KF; de Beyer JA; Hansen Nejstgaard C; Østengaard L; Hopewell S
    J Clin Epidemiol; 2024 May; 169():111309. PubMed ID: 38428538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
    Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
    Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.
    Elsman EBM; Butcher NJ; Mokkink LB; Terwee CB; Tricco A; Gagnier JJ; Aiyegbusi OL; Barnett C; Smith M; Moher D; Offringa M
    Syst Rev; 2022 Jun; 11(1):121. PubMed ID: 35698213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ;
    Lancet Digit Health; 2020 Oct; 2(10):e549-e560. PubMed ID: 33328049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
    Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.
    Manyara AM; Davies P; Stewart D; Weir CJ; Young A; Butcher NJ; Bujkiewicz S; Chan AW; Collins GS; Dawoud D; Offringa M; Ouwens M; Ross JS; Taylor RS; Ciani O
    BMJ Open; 2022 Oct; 12(10):e064304. PubMed ID: 36220321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.
    Solovyeva O; Dimairo M; Weir CJ; Hee SW; Espinasse A; Ursino M; Patel D; Kightley A; Hughes S; Jaki T; Mander A; Evans TRJ; Lee S; Hopewell S; Rantell KR; Chan AW; Bedding A; Stephens R; Richards D; Roberts L; Kirkpatrick J; de Bono J; Yap C
    BMC Med; 2023 Jul; 21(1):246. PubMed ID: 37408015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
    Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
    Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol.
    Manyara AM; Davies P; Stewart D; Wells V; Weir C; Young A; Taylor R; Ciani O
    BMJ Open; 2022 Oct; 12(10):e062798. PubMed ID: 36229145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.
    Cruz Rivera S; Liu X; Chan AW; Denniston AK; Calvert MJ; ; ;
    Nat Med; 2020 Sep; 26(9):1351-1363. PubMed ID: 32908284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.